SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001410578-19-001626
Filing Date
2019-10-11
Accepted
2019-10-11 08:46:14
Documents
12
Period of Report
2019-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tv530933_8ka.htm   iXBRL 8-K/A 24335
  Complete submission text file 0001410578-19-001626.txt   197932

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA egrx-20190828.xsd EX-101.SCH 3183
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE egrx-20190828_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE egrx-20190828_pre.xml EX-101.PRE 22708
8 EXTRACTED XBRL INSTANCE DOCUMENT tv530933_8ka_htm.xml XML 3621
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36306 | Film No.: 191147092
SIC: 2834 Pharmaceutical Preparations